Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia

Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia

US Patent 6979680 · Granted Dec 27, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Background audio identification for query disambiguation2024
Providing answers to voice queries using user feedback2024
Method of predicting response to therapy by assessing tumor genetic heterogeneit2024
Background audio identification for speech disambiguation2024
Providing answers to voice queries using user feedback2023
Non-invasive test to predict recurrence of colorectal cancer2023
Use of PRG4 as an anti-inflammatory agent2023
Audio announcement prioritization system2023
Background audio identification for query disambiguation2023
Background audio identification for speech disambiguation2023
Non-invasive test to predict response to therapy in colorectal cancer patients2022
Providing answers to voice queries using user feedback2022